Ocera Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Trademark Applications
Trademark applications show the products and services that Ocera Therapeutics is developing and marketing.
Ocera Therapeutics doesn't have any recent trademark applications, indicating Ocera Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
ZYSA Pharmaceutical preparations for the treatment of gastrointestinal and hepatic conditions and diseases
04/12/2012
RESYNCLA Pharmaceutical preparations for human use
02/06/2012
KINMOTA Pharmaceutical preparations for human use
02/06/2012
See all trademarks and details in the Full Report.
Market Share of Ocera Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Ocera Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Ocera Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Ocera Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.